<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Salzmann RJS</submitter><pubmed_abstract>Human-derived biomaterials offer several advantages over animal-derived or synthetic alternatives, including improved biocompatibility, ethical acceptability, sustainability, and clinical translatability. Here we present new applications of human placenta-derived materials - specifically HUMAN PLACENTA substrate, collagen type-I, and Laminin-111 - as 2D coating materials and 3D matrices for the cultivation of spheroids and adherent cells. Collagen type-I coatings supported colorectal cancer spheroid formation without the need for growth-factor supplementation. Lm-111 significantly enhanced NIH3T3 fibroblast adhesion compared with poly-L-lysine and rat-tail collagen type-I, performing comparably to bovine fibronectin. In a transwell blood-brain barrier model, HUMAN PLACENTA substrate coatin</pubmed_abstract><journal>Frontiers in bioengineering and biotechnology</journal><pagination>1676369</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12808481</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>New applications of sustainable, scalable, standardized, and cost-effective human biomaterials for cell-based assays, tissue engineering, and regenerative medicine.</pubmed_title><pmcid>PMC12808481</pmcid><pubmed_authors>Moroni L</pubmed_authors><pubmed_authors>Salzmann RJS</pubmed_authors><pubmed_authors>Kigili S</pubmed_authors><pubmed_authors>Neuhaus W</pubmed_authors><pubmed_authors>Hackethal J</pubmed_authors><pubmed_authors>Egger G</pubmed_authors><pubmed_authors>Prado-Lopez S</pubmed_authors><pubmed_authors>Domazet S</pubmed_authors><pubmed_authors>Brachner A</pubmed_authors></additional><is_claimable>false</is_claimable><name>New applications of sustainable, scalable, standardized, and cost-effective human biomaterials for cell-based assays, tissue engineering, and regenerative medicine.</name><description>Human-derived biomaterials offer several advantages over animal-derived or synthetic alternatives, including improved biocompatibility, ethical acceptability, sustainability, and clinical translatability. Here we present new applications of human placenta-derived materials - specifically HUMAN PLACENTA substrate, collagen type-I, and Laminin-111 - as 2D coating materials and 3D matrices for the cultivation of spheroids and adherent cells. Collagen type-I coatings supported colorectal cancer spheroid formation without the need for growth-factor supplementation. Lm-111 significantly enhanced NIH3T3 fibroblast adhesion compared with poly-L-lysine and rat-tail collagen type-I, performing comparably to bovine fibronectin. In a transwell blood-brain barrier model, HUMAN PLACENTA substrate coatin</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-12T04:54:09.722Z</modification><creation>2026-06-12T03:08:02.546Z</creation></dates><accession>S-EPMC12808481</accession><cross_references><pubmed>41550371</pubmed><doi>10.3389/fbioe.2025.1676369</doi></cross_references></HashMap>